New Kink in the Link Between GLP-1 Drugs and Cognition

(MedPage Today) -- Adults whose type 2 diabetes was treated with GLP-1 receptor agonists were more than likely to develop cognitive impairment over 10 years than their counterparts not treated with GLP-1 agents, a propensity-matched retrospective...
Source
MedPage Today
Opens original article in a new tab



